Development of a targeted polymorph screening approach for a complex polymorphic and highly solvating API.
about
Polymorph Impact on the Bioavailability and Stability of Poorly Soluble DrugsMulticomponent chemical imaging of pharmaceutical solid dosage forms with broadband CARS microscopy.The solid-state continuum: a perspective on the interrelationships between different solid-state forms in drug substance and drug product.Why do Hydrates (Solvates) Form in Small Neutral Organic Molecules? Exploring the Crystal Form Landscapes of the Alkaloids Brucine and Strychnine.Can computed crystal energy landscapes help understand pharmaceutical solids?Epalrestat tetra-hydro-furan monosolvate: crystal structure and phase transition.Computational and Experimental Characterization of Five Crystal Forms of Thymine: Packing Polymorphism, Polytypism/Disorder and Stoichiometric 0.8-HydrateStoichiometric and Non-Stoichiometric Hydrates of Brucine.Unraveling Complexity in the Solid Form Screening of a Pharmaceutical Salt: Why so Many Forms? Why so Few?Crystal forms of SK-3530.Close intramolecular sulfur-oxygen contacts: modified force field parameters for improved conformation generation.Analysis of the conformational profiles of fenamates shows route towards novel, higher accuracy, force-fields for pharmaceuticals.The polymorphs of ROY: application of a systematic crystal structure prediction technique.Supramolecular Organization of Nonstoichiometric Drug Hydrates: Dapsone.
P2860
Q26779030-92BC0D07-FDF9-44D4-85FE-5A56BC457472Q37693295-4C5999FE-9671-43EC-A2E2-A331522B5DE0Q38239948-A6CA06C6-E06C-41CE-B51C-5E290FDF19A5Q38697551-0D58E278-6EFB-4F8D-ABC7-B05D9B994E55Q38805031-151868EF-2DDF-48A6-8107-E38A29C3B053Q40953361-4495927F-1AD7-42E3-8294-BC70038C257CQ41031460-AC32C0B0-2EB6-4C48-9657-46A8FCFED705Q41671576-8D82551E-BB97-44C7-AC68-0E24B0DF3494Q42276818-FEADA40B-FF99-4B51-B7C9-52CE9A59B38AQ42769906-60B5BD1D-B775-40AD-8C5C-154B7DFA5768Q44670603-D0768D9F-AE55-4F76-965B-61B786B1AA17Q47672943-493836C7-A406-4261-A50F-27240753DD89Q50500185-2BCAD112-FA67-4210-83FC-0E18B2730D41Q53438493-B44D655A-E47A-4823-8E86-EB13EF074CC2
P2860
Development of a targeted polymorph screening approach for a complex polymorphic and highly solvating API.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Development of a targeted poly ...... phic and highly solvating API.
@en
Development of a targeted poly ...... phic and highly solvating API.
@nl
type
label
Development of a targeted poly ...... phic and highly solvating API.
@en
Development of a targeted poly ...... phic and highly solvating API.
@nl
prefLabel
Development of a targeted poly ...... phic and highly solvating API.
@en
Development of a targeted poly ...... phic and highly solvating API.
@nl
P2093
P356
P1476
Development of a targeted poly ...... phic and highly solvating API.
@en
P2093
Anthony M Campeta
Brian P Chekal
Keith R Horspool
Mark J Henson
Paul A Meenan
Robert A Singer
Yuriy A Abramov
P304
P356
10.1002/JPS.22230
P407
P577
2010-09-01T00:00:00Z